학술논문
Safety and Efficacy of SBI-087, a Subcutaneous Agent for B Cell Depletion, in Patients with Active Rheumatoid Arthritis: Results from a Phase II Randomized, Double-blind, Placebo-controlled Study.
Document Type
journal article
Author
Source
Journal of Rheumatology; Dec2016, Vol. 43 Issue 12, p2094-2100, 7p
Subject
Language
ISSN
0315162X